|
subject |
user |
date & time |
rating |
|
|
|
Cardium Therapeutics, Inc. (CXM) Trims Q1 2013 Loss, Improves Sales Cardium Therapeutics today presented its financial results for the first quarter ended March 31, 2013, and reported on highlights and other recent developments. The company narro...
|
|
5/15/2013 10:19:08 AM |
|
|
|
Cardium Therapeutics, Inc. (CXM) Plays Two Vital Roles in the Fight Against Diabetes As hard as it may seem to believe, the American Diabetes Association says that over 8% of the U.S. population, roughly 1 out of 12 Americans, now has diabetes. T... |
|
5/10/2013 5:16:00 PM |
|
|
|
|
Cardium Therapeutics, Inc. (CXM) CEO Dr. Rubanyi Authors Generx Publication in Molecular Therapy Cardium Therapeutics, an asset-based health sciences and regenerative medicine company, today highlighted the publication, “Mechanistic, Techni...
|
|
5/2/2013 10:48:59 AM |
|
|
|
Cardium Therapeutics, Inc. (CXM) to Showcase Excellagen® in Poster Presentation at the 2013 Spring SAWC/WHS Meeting Cardium Therapeutics, an asset-based health sciences and regenerative medicine company, is scheduled to present a poster demon... |
|
4/30/2013 10:25:59 AM |
|
|
|
|
Cardium Therapeutics, Inc. (CXM) Looks to Future with Three-Stage Growth Plan Cardium Therapeutics is a San Diego based health sciences and regenerative medicine company that has carefully diversified itself with a strategy designed to provide sh...
|
|
4/29/2013 1:45:19 PM |
|
|
|
Cardium Therapeutics, Inc. (CXM) Continues with Growth Strategy Implementation When Cardium Therapeutics recently released their 2012 financial results, reflecting the company’s extensive investment required for the important introduction o... |
|
4/19/2013 12:00:33 PM |
|
|
|
|
Cardium Therapeutics, Inc. (CXM) Excellagen Commercialization Plans Cardium Therapeutics, a medical technology company focused on cardiovascular and tissue repair, has developed and is implementing a comprehensive commercialization strategy for E...
|
|
4/12/2013 5:33:44 PM |
|
|
|
Cardium Therapeutics, Inc. (CXM) Reports 2012 Financial Results, Recent Developments, and Financing Today before the opening bell, Cardium made a series of announcements as well as provided a comprehensive update on its ongoing initiatives. An ab... |
|
4/5/2013 1:12:20 PM |
|
|
|
|
Cardium Therapeutics, Inc. (CXM) Addresses the High Cost of Heart Surgery The number and degree of medical advances over the past 50 years is astonishing, offering hope for the afflicted never before possible or even imaginable. But it’s ho...
|
|
4/1/2013 3:45:09 PM |
|
|
|
Cardium Therapeutics, Inc. (CXM) Builds a Diverse Approach to the Medical and Health Marketplace Cardium Therapeutics is implementing a broad-based strategy of engaging the medical and health marketplace, focused on opportunities offering a clear... |
|
3/20/2013 10:05:41 AM |
|
|
|
|
Cardium Therapeutics, Inc. (CXM) Excellagen Wound Care Product Receives ISO Certification Today before the bell, Cardium Therapeutics announced that it has received ISO 13485:2003 certification for its Excellagen® advanced wound care product ...
|
|
3/14/2013 10:33:13 AM |
|
|
 |
Cardium Therapeutics, Inc. (CXM) Prepares Launch of Expanded VitaRocks® kids Vitamin Line with New Retail Distribution Earlier today, Cardium Therapeutics announced that its To Go Brands® division has expanded its VitaRocks® kids vita... |
|
3/13/2013 12:26:02 PM |
4 |
|
|
|
Cardium Therapeutics, Inc. (CXM) Generx Cardiovascular Solution Marches to a Different Beat Coronary artery disease – the No. 1 cause of death worldwide – kills more than 17 million people around the world each year. It’s easy t...
|
|
2/28/2013 5:27:33 PM |
|
|
|
Cardium Therapeutics, Inc. (CXM) and the Generx Strategy Cardium Therapeutics’ lead clinical development product candidate is Generx, a DNA-based angiogenic growth factor therapeutic being developed for the potential treatment of patients w... |
|
2/20/2013 11:56:44 AM |
|
|
|
|
Cardium Therapeutics, Inc. (CXM) Wound Care Product Awarded Seal of Approval by American Podiatric Medical Association Today before the opening bell, Cardium Therapeutics announced that the American Podiatric Medical Association (APMA) has grante...
|
|
2/12/2013 1:17:33 PM |
|
|
|
Cardium Therapeutics, Inc. (CXM) Commercialization Status for Excellagen Cardium Therapeutics has a capital-efficient, asset-based business strategy focused on building a diversified portfolio of new and innovative bio-medical product opportuniti... |
|
2/5/2013 4:31:39 PM |
|
|
|
|
Cardium Therapeutics, Inc. (CXM) Presents at the 2013 Cell & Gene Therapy Forum Today before the opening bell, Cardium Therapeutics announced its Chief Scientific Officer, Gabor M. Rubanyi, M.D., Ph.D. delivered a presentation at the 2013 Pha...
|
|
1/29/2013 10:29:46 AM |
|
|
|
To Go Brands Continues to Provide Support to Cardium Therapeutics, Inc. (CXM) Cardium Therapeutics is a health sciences and regenerative medicine company focused on the acquisition and strategic development of innovative health products. As an im... |
|
1/24/2013 4:52:53 PM |
|
|
|
|
Cardium Therapeutics, Inc. (CXM) To Go Brands Vitamins for Children One of the challenges of every parent is ensuring that their children get the kind of nutrition they need. You can avoid keeping junk foods around the house, and make a point of ...
|
|
1/17/2013 5:10:44 PM |
|
|
|
Cardium Therapeutics, Inc. (CXM) Presentation Summarizes Platforms and Strategy When health sciences and regenerative medicine company Cardium Therapeutics made their presentation recently at the Biotech Showcase Conference in San Francisco, they... |
|
1/10/2013 5:24:07 PM |
|
|
|
|
Cardium Therapeutics, Inc. (CXM) Scheduled to Present at Biotech Showcase 2013 Investment Conference Earlier this morning, Cardium Therapeutics announced that its CEO will be presenting at the Biotech Showcase 2013 Conference. This year the annua...
|
|
1/4/2013 11:44:31 AM |
|
|
|
Cardium Therapeutics, Inc. (CXM) to Increase Excellagen Clinical Adoption by U.S. Government Medical Providers via New Distribution Agreement Today before the opening bell, Cardium Therapeutics announced it has entered a distribution agreement wi... |
|
1/3/2013 11:15:49 AM |
|
|
|
|
Cardium Therapeutics, Inc. (CXM) Promotes Wellness and Prevention When Cardium Therapeutics recently acquired To Go Brands, a San Diego based nutraceuticals developer, it was a major expansion of Cardium’s original Medpodium nutraceutical l...
|
|
12/31/2012 5:38:57 PM |
|
|
|
Excellagen Plays Leading Role for Cardium Therapeutics, Inc. (CXM) A major part Cardium’s product candidate portfolio, and the company’s overall strategy, is Excellagen, an acellular biological modulator for advanced wound care manage... |
|
12/18/2012 7:28:18 PM |
|
|
|
|
Latest Investor Summary Posted http://cxm.missionir.com/ir Please read full disclaimers at http://disclaimer.missionir.com
|
|
12/12/2012 11:13:01 AM |
|
|
Stockhouse.com: Taking
it to the street
